Shufang Wu, 2003 [99] |
Sprague Dawley rats |
Treat with inhibitor of the cholesterol synthesis |
Cholesterol production suppression inhibits chondrocyte proliferation, hypertrophy, and differentiation. Cholesterol controls growth plate chondrogenesis and longitudinal bone formation, potentially through enhancing IHH’s action in the growth plate. |
H. Kishimoto, 2010 [104] |
Bovine articular chondrocytes |
Treat with ox-LDL |
ox-LDL stimulates the hypertrophy of OA chondrocytes, in part, through binding to LOX-1. The binding of ox-LDL to LOX-1 promotes intracellular ROS generation and oxidative stress in chondrocytes. |
Aspasia Tsezou, 2010 [106] |
Human chondrocytes with OA |
Treat with LXR agonist |
In osteoarthritis patients, the expression of ABCA1 and ApoA1 transcriptional regulators LXRa and LXRb was dramatically reduced. LXR agonists enhance cholesterol efflux in chondrocytes with osteoarthritis. |
C. Gentili, 2005 [109] |
Chick chondrocytes |
Treat with LXR/RXR agonists |
Chondrocytes manufacture ApoA1 during development, and ligands that activate LXR or RXR may lead to a significant increase in ApoA1 expression and cholesterol efflux in thicker chondrocytes. Other LXR target genes are implicated in cholesterol transport and homeostasis, including ABCA1 and SREBP1. The expression of chondrocyte SAA is inhibited by ligands that activate LXR or RXR and induce ApoA1. |
Dominique de Seny, 2015 [110] |
Human chondrocytes with OA |
Incubation with ApoA1, rhSAA, HDL, LDL |
By boosting TLR4 activation, free ApoA1 particles in OA joints may directly or indirectly contribute to the local inflammatory process. ApoA1’s inflammatory characteristics on chondrocytes and fibroblast-like synoviocytes will be influenced by HDL and LDL concentrations that are tightly regulated. |
Wouter de Munter, 2013 [112] |
LDL receptor-deficient and wild-type control mice with OA |
Cholesterol-rich diet |
In OA, elevated LDL cholesterol levels stimulate the development of ectopic bone. The underlying process may include TGF -β activation and, to a lesser degree, BMP activation after ox-LDL absorption by synovial intimal macrophages. |
W an-Su Choi, 2019 [113] |
Mice with OA |
High-cholesterol diet vs. regular diet |
In osteoarthritic chondrocytes, increased cholesterol absorption, cholesterol hydroxylase levels, and hydroxysterol metabolite synthesis directly activate ROR, contributing to the pathogenesis of OA. Through LOX1-mediated augmentation of CH25H and CYP7B1 absorption and metabolism, increased cholesterol levels in chondrocytes induce experimental OA in mice. The CH25H-CYP7B1-ROR axis of cholesterol metabolism in chondrocytes is a crucial catabolic regulator in the etiology of osteoarthritis. |
Margaret Man-Ger Sun, 2020 [114] |
Mice primary chondrocytes |
Treat with specific LXRagonist |
Upon activation by its specific agonist, the LXR-Srebp1-Scd1 axis functions as a cholesterol sensor, lowering the buildup of free cholesterol in cells to mitigate cholesterol’s cytotoxic effects. LXR is activated by its particular agonist, and LXR’s protective impact on OA may be mediated, in part, by increased cholesterol excretion and suppression of chondrocyte hypertrophy. |
Fotini Kostopoulou, 2015 [116] |
Human cartilage with OA |
Treat with TGF-β1 |
miR-33a may influence the TGF-1/PI3K/Akt signaling pathway via the regulation of Smad7 expression. MiR-33 inhibition in OA chondrocytes raises the levels of ABCA1 and HDL, resulting in a reduction in MMP-13 expression. |
Shirou Tabe, 2017 [122] |
ATDC5 cells |
Silence LPCA4 expression |
Other than Col2, Sox9, and Runx2, knockdown of LPCAT4 decreased the mRNA expression of chondrogenic differentiation-related molecules. The expression of LPCAT4 rises during chondrogenic differentiation, and LPCAT4 is implicated in chondrocyte hypertrophy. |
Mi-Kyoung Kim, 2006 [124] |
Rat primary chondrocytes |
Treat with S1P and PhS1P |
Sphingosine kinase-1 is the key to the production of S1P from sphingosine. S1P and PhS1P lead to cellular proliferation of rat primary chondrocytes through a ptx-sensitive G-protein-mediated pathway, plc-mediated [Ca2+] increase and activation of MAPKs. |
Hongming Miao, 2015 [79] |
Male C57BL/6 mice |
HFD |
In a way reliant on LDH-a, circulating stearic acid elevates lactate levels in plasma and chondrocytes. Stearic acid increases the production of VEGF and cytokines that cause inflammation through a TLR4 pathway and a new lactate/HIF1 pathway. |
Oscar lvarez-Garcia, 2014 [80] |
Human chondrocytes and fibroblast-like synoviocytes |
Human chondrocytes from normal and OA were treated with Palmitate or oleate in combination with IL-1 |
Palmitate, but not oleate, stimulates IL-1 in normal chondrocytes, causing caspase activation and cell death, and upregulates IL-6 and COX2 in chondrocytes and fibroblast-like synoviocytes through Toll-like receptor-4 signaling. |
Daniel edina-Luna, 2017 [81] |
Human chondrocytes |
Treatment with FFA blend consisting of palmitic and oleic acids vs. control |
A high-fat milieu causes cartilage degradation by raising chondrocyte IL-1, ROS, and RNS, promoting autocrine production of IL-6 and IL-8. |
Chia-Lung Wu, 2014 [75] |
Mice with OA |
HFD, rich in SFAs, n-3 PUFAs, n-6 PUFAs |
n-3 PUFA supplementation may reduce the effects of obesity on OA and enhance healing. SFAs and omega-6 PUFAs are both harmful in OA following joint damage. SFAs may cause synovial macrophages to release IL-1 and TNF, both of which are implicated in cartilage degradation. |
M. Miyamoto, 2003 [88] |
Primary chondrocytes from rat rib cartilage |
Treat with PGE2 |
Simultaneous stimulation of EP2 and EP4 induces chondrocyte differentiation |
H. Davis Adkisson, 1991 [85] |
Cartilage from multiple species |
Argentation high-performance liquid chromatographic(AHPLC) separationof fatty acid |
Low levels of n-6 PUFAs and high levels of abnormal n-9 fatty acids found in normal cartilage |
Kohei Nishitani, 2010 [89] |
Human chondrocytes |
Treat with PGE2 |
PGE2 inhibits IL-1β-induced MMP-1 and MMP-13 synthesis through EP4 activation and suppression of MKK4, JNK MAP kinase, and c-JUN phosphorylation. |
Sunderajhan Sekar, 2017 [73] |
Rat |
High-Carbohydrate Supplements with SFAs vs. cornstarch diet |
High-fat diet can induce metabolic syndrome in rats. Palmitic acid and stearic acid combined with IL-1 mediate cartilage damage by increasing MMP-13, ADAMTS-4, and ADAMTS-5 gene expression and increase the severity of OA |
Sujeong Park, 2022 [74] |
ACOT12 knockout mice |
Treatment with specific agonists and inhibitors of PPARα |
ACOT12 is involved in maintaining cartilage homeostasis. Increased accumulation of acetyl-CoA due to PPARα deficiency leads to stimulation of cartilage-degrading enzymes and chondrocyte apoptosis through regulation of ACOT12. |